AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Oncology-focused biopharma reports record product revenues Q2 2004.
2004 SEP 2 - (NewsRx.com & NewsRx.net) -- Cytogen Corp. sshearer@cytogen.com
Cytogen Corp. (CYTO), a product-driven, oncology-focused biopharmaceutical company, reported its consolidated financial results for the second quarter and 6 months ended June 30, 2004 and reaffirmed its 2004 full-year financial guidance.
Second-quarter sales were strong with total product revenues of $3.9 million for the quarter ended June 30, 2004 compared to $1.7 million for the same period in 2003. For the 6 months ended June 30, 2004, product revenues were $7.5 million compared to $3.6 million for the same period in 2003.
Cytogen reported a net loss of $4.4 million, or $0.30 per basic and diluted share, for the quarter ended June 30, 2004 compared to a net loss of $3.4 million, or $0.37 per basic and diluted share, for the same period in 2003. For the 6 months ended June 30, 2004, Cytogen reported a net loss of $8.7 million, or $0.63 per basic and diluted share, compared to $5.3 million, or $0.60 per basic and diluted share for the same period in 2003.
"We are very pleased to report another quarter of significant progress at Cytogen," said Michael D. Becker, Cytogen's president and CEO. ...
- Rock-Tenn Company Reports Record Earnings of $0.63 per diluted share for the...
- Press release article from: Business Wire July 24, 2007 700+ words
...for the quarter ended June 30, 2007 of $0.63 per diluted share on record quarterly...or $0.01 per diluted share after-tax. Income...or $0.05 per diluted share after-tax. Segment...the twelve months ended June 30, 2007 of...
- Nassda Announces Revenue of $7.5 Million for the Quarter Ended June 30, 2003...
- Press release article from: PR Newswire July 16, 2003 700+ words
...the quarter ended June 30, 2003 was...0.01 per diluted share, a decrease...0.06 per diluted share, for the quarter ended June 30, 2002 and...0.15 per diluted share, for the nine months ended June 30, 2002...
- Hanger Orthopedic Group, Inc. Announces Revenue of $152.9 Million and Pro-Forma...
- Press release article from: PR Newswire July 26, 2006 700+ words
...0.13 per diluted share, for the quarter ended June 30, 2006...0.42) per diluted share for the quarter ended June 30, 2006...0.11 per diluted share, in the prior...the six months ended June 30, 2006 increased...
- Hanger Orthopedic Group, Inc. Announces Net Income Applicable to Common Stock...
- Press release article from: PR Newswire July 30, 2007 700+ words
...0.17 per diluted share, for the quarter ended June 30, 2007...0.42 per diluted share in the same...the quarter ended June 30, 2007...0.42 per diluted share. Net sales...six months ended June 30, 2007...
- Hanger Orthopedic Group, Inc. Announces Net Income Per Diluted Share of $0.11...
- Press release article from: PR Newswire July 27, 2005 700+ words
...net income per diluted share of $0.11 for the quarter ended June 30, 2005. Net...approximately $0.11 per diluted share, compared to...approximately $0.10 per diluted share, in the prior...the six months ended June 30, 2005 increased...
- Optimal Group Announces Second Quarter 2006 Results; $0.28 per diluted share in...
- Press release article from: Business Wire August 7, 2006 700+ words
...million or $1.22 per diluted share, for the quarter ended June 30, 2005. Net earnings per diluted share from continuing operations...FireOne of $1.22 per diluted share, for the six months ended June 30, 2005. Net earnings...
- Styling Technology Corp. Corrects Earnings per Diluted Share Data in Table of...
- Press release article from: Business Wire August 11, 1999 700+ words
...share amounts) Six Months Ended June 30 1999 Earnings per Diluted Share before Centralization and...Taxes) $ 0.79 Earnings per Diluted Share before Extraordinary Item $ (0.18) Earnings per Diluted Share after Extraordinary Item...
- Hawthorn Bancshares Announces 2nd Quarter Earnings of $0.31 Per Diluted...
- Press release article from: Business Wire July 30, 2008 700+ words
...quarter of 2008. For the three months ended June 30, 2008, earnings per diluted share were $0.31, up 19% from the previous...2007. For the six-month period ended June 30, net income per diluted share was $0.57 in 2008 compared with...
Source: HighBeam Research, Oncology-focused biopharma reports record product revenues Q2 2004.